It tells you where it does not go
WeightCare states outright that it does not serve Alaska, Hawaii, Mississippi or Louisiana, and that one of its micro-dosing programs excludes nine states on top of that.
Most sellers on these boards publish nothing at all about where they operate, or publish a sentence about availability varying by state and leave you to guess.
The catch is placement. Both the exclusions and the pharmacy language sit inside collapsed accordions rather than in the page body, so a reader scanning the product page never meets them. The disclosure is real; it is just not offered.
Three prices per drug, and the headline is the longest plan
For each compound WeightCare publishes a six-month rate, a three-month rate and a month-to-month rate, each stated per month, on the same page.
The advertised figure is the six-month one. The no-commitment rate is far higher for both drugs, and the three-month rate sits between them.
Printing all three side by side is the genuinely useful part. Most sellers advertise their longest-commitment rate and make you find the short-term price at checkout, if at all.
It lets you price your own uncertainty rather than guess at it. If you are not sure a GLP-1 will suit you, you can see exactly what six months of confidence would have saved.
Every dose is included, so the bill does not climb
WeightCare's plan comparison states that all doses are included. Its program summary lists the initial telehealth visit, prescription and medication, unlimited physician support and monthly check-ins.
Titrating up is where a lot of GLP-1 budgets break. Several sellers in this comparison price by dose, so the number that looked cheap at the starting dose is not the number you pay at a therapeutic one.
A flat rate that survives escalation is worth more than a lower starting figure that does not. Set WeightCare's six-month rate against a dose-priced rival at your likely maintenance dose, not at week one.
Compounded only, and the pharmacy is unnamed
WeightCare sells compounded semaglutide and compounded tirzepatide. A census of its 39 product pages turned up no FDA-approved brand.
If coverage might come through for an approved drug, this is not the platform for that. Eden prices the compounded and brand-name routes on one page, and Nurx prescribes brands only.
The pharmacy layer is thin. WeightCare describes an accredited pharmacy and a state-licensed sterile compounding pharmacy partner, and names neither. It does name its own operating company, Weightless Medical LLC, in the Terms of Service.
What to check before you commit six months
The six-month rate is the number the site leads with, and six months is a long time to be locked to a seller you have not used.
Ask what happens if you stop: whether the balance is refundable, prorated, or neither. WeightCare publishes the prices clearly but the exit terms are worth having in writing.
Ask which pharmacy is filling your order, too. Getting a name at intake is not the same as the company publishing one, but it gives you something to check.
WeightCare's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $215/mo"6-MONTH PLAN" at "$215" "/ PER MONTH". The same page also lists "3-MONTH PLAN" at "$249 / PER MONTH" and "MONTHLY" at "$399 / PER MONTH" with "NO COMMITMENT". The program summary lists "Initial Telehealth Visit", "Prescription + Medication", "Unlimited Physician Support" and "Monthly Check-ins", and the plan comparison says "ALL DOSES" are included. No separate membership fee is published. | September 2026source |
| Tirzepatide (compounded) | $275/mo"6 MONTH PLAN" at "$275" "/ PER MONTH", flagged "BEST VALUE". The same page lists "3 MONTH STARTER" at "$299 / PER MONTH" and "MONTHLY" at "$499 / PER MONTH" with "NO COMMITMENT". | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 38 providers reviewed here are paid partners today; the other 34 are not. See how this works.
See WeightCare's current price →Good fit if
- Readers who want to know whether a seller operates in their state before starting an intake.
- Patients comparing commitment lengths who want the month-to-month price and the six-month price side by side.
- People who expect to titrate up and want a rate that does not move with the dose.
- Readers who want the operating company named in the terms rather than only a brand.
Look elsewhere if
- Anyone in Alaska, Hawaii, Mississippi or Louisiana, which WeightCare states it does not serve.
- Patients who want an FDA-approved brand. A census of 39 WeightCare product pages found none; Eden prices both routes and Nurx sells brands only.
- Readers who need the compounding pharmacy named. Willow names five with street addresses and Belle Health names more than one.
- Anyone unwilling to commit for six months, since the month-to-month rate is far above the advertised figure.
How this review was verified
- Read WeightCare's semaglutide and tirzepatide program pages at their source URLs and logged all three commitment-length figures for each drug with the date they were read.
- Carried the plan length into every qualifier, so the advertised six-month rate cannot be compared against another seller's month-to-month price without the difference showing.
- Recorded what the plan comparison says is included, including the line that all doses are covered, using WeightCare's own wording.
- Expanded the collapsed accordions on the product pages, which is where the excluded states and the pharmacy language live, and logged both.
- Censused 39 WeightCare product pages for an FDA-approved brand-name GLP-1 and found none, and the count is recorded alongside the claim.
- Confirmed the operating company from WeightCare's own Terms of Service.